TECH Stock Recent News
TECH LATEST HEADLINES
Bio-Techne ( TECH , Financial) also suffered from a shift away from growth stocks by investors. Despite the company's fundamental outlook improving on a number of future growth initiatives, the stock still finished down 35.70% for the year.
REGN vs. TECH: Which Stock Is the Better Value Option?
GSK vs. TECH: Which Stock Is the Better Value Option?
MINNEAPOLIS , Dec. 21, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 8:15 a.m.
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
If there's a silver lining regarding the coronavirus pandemic, it's that it demonstrated the importance of the top biotech stock picks for 2023. While medical innovations may seem frustratingly slow, the Covid-19 crisis proved that when humanity comes together, it can foster incredible advancements at breakneck speed.
MINNEAPOLIS , Nov. 28, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Fifth Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 8:50 a.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
VRTX vs. TECH: Which Stock Is the Better Value Option?
Bio-Techne has endured a beating on the chart in FY22 as investors unwound health care and medtech positions en masse. After 4x attempts to recover its FY21 highs, TECH looks to have potentially bottomed as weekly volume gathers steam.
Bio-Techne Corporation (NASDAQ:TECH ) Q1 2023 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Chuck Kummeth - President, Chief Executive Officer Jim Hippel - Executive Vice President, Chief Financial Officer David Clair - Vice President, Investor Relations Conference Call Participants Puneet Souda - SVB Securities Dan Arias - Stifel Dan Leonard - Credit Suisse Anna - Stephens Alex Nowak - Craig Hallum Catherine Schulte - Baird Patrick Donnelly - Citi Operator Good morning and welcome to the Bio-Techne earnings conference call for the first quarter of fiscal year 2023. At this time, all participants have been placed in listen-only mode.